Pioneering stem cell trial

Doctors in Scotland working with British biotech company ReNeuron have treated the first patient in a pioneering clinical trial to test whether stem cell therapy can help patients disabled by stroke.

The trial is the first in the world to use neural stem cell therapy in stroke patients, its organisers said recently, and external experts said it was grounds for “cautious optimism.”

Keith Muir of the University of Glasgow's Institute of Neuroscience and Psychology, the principal investigator, said the first patient had undergone a successful surgical procedure and been discharged from hospital.